Pharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosing
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 2, 2026
October 7, 2026
a6613274-1ed5-414e-b72d-168058dfe307
Related Documents
Quantitative Systems Pharmacology (QSP)-Based Dose Selection for Minimum Anticipated Biological Effect Level (MABEL) in First-in-Human (FIH) Trials
Guidance DocumentJune 24, 2026Center for Drug Evaluation and Research
Clinical Pharmacology Considerations for Peptide Drug Products
Guidance DocumentDecember 14, 2023Center for Drug Evaluation and Research
Pharmacokinetics in Pregnancy — Study Design, Data Analysis, and Impact on Dosing and Labeling
Guidance DocumentNovember 1, 2004Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.